Novo wins new use for Levemir in kids; Can Lundbeck's new antidepressant beat existing meds?;

 @FiercePharma:  Counterfeit drugs threaten strides against malaria; Some companies trying text technology to combat fakes. More | Follow @FiercePharma

> Novo Nordisk ($NVO) won the FDA nod for expanded use of its insulin drug Levemir, to treat young children with Type 1 diabetes. Report

> Lundbeck's bid to replace outgoing antidepressant Lexapro/Cipralex got a boost from new data, but it's unclear whether the new drug would beat existing therapies. News

> Senate Majority Leader Harry Reid warned that the Senate could move to other legislation if a fight over new amendments to the new user-fee bill isn't resolved. Article

> A new bill in Congress aims to curb drug shortages by policing drug wholesalers to prevent gray-market sales. Story

> Bayer HealthCare denied promoting its anti-clotting drug Xarelto for off-label use in China after a physician accused it of promoting the new drug for an unapproved indication. Item

Biotech News

 @FierceBiotech: Chasing a holy grail in pharma, Novo confident that it can crack blockbuster oral insulin market. More | Follow @FierceBiotech

 @JohnCFierce: Top biotechs boosted R&D spending 13% last year, and trend still points north. Special Report on biggest R&D spenders. Item | Follow @JohnCFierce

 @RyanMFierce: Pfizer is offering heart-healthy recipes via a mobile app. The message: Eat well, take Lipitor. More | Follow @RyanMFierce

> French biotechs afflicted by a plunge in financial support. News

> Pharma VC embrace improves a biotech's chance of success. Article

> InterMune deal delivers $55M in fresh fuel for fibrosis drug. Story

Medical Devices News

 @FierceMedDev:  Medtronic is taking an $87M charge to cover ongoing layoff costs in the U.S. Report | Follow @FierceMedDev

 @MarkHFierce: Please submit your nominations soon for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Abiomed stock hammered over Impella reimbursement risk rumors. More

> Healthsense, a crafter of wireless device monitors, seeks $13.7M. Article

> In India, device companies will succeed by going local. Commentary

Drug Delivery News

 @DamianFierce: Prosonix says its new delivery platform makes combined APIs more effective: Story | Follow @DamianFierce

> Delivery method could help regenerate heart tissue. More

> Impax cited by FDA in manufacturing inspection. Story

> BDSI snags $2.5M milestone from Meda. Report

Biomarkers News

> HDL isn't clear-cut biomarker, study suggests. News

> Gut microbe signature could tag radiation exposure. Story

> Blood test for bowel cancer is in the DNA. More

> Are you hungry? Biomarker spots preemies ready to feed. Article

And Finally... A new study finds that the benefits of hormone therapy outweigh the risks in women who use it earlier in menopause. Report